Why can a soft sock hurt? Why might a child not act on a bodily need? How can someone know what to do and still struggle to do it? These questions concern the brain and body together, as well as the demands of the situation.
A biological explanation should help us listen and respond. A child does not need to demonstrate a laboratory mechanism before their experience matters. Equally, a diagnosis does not tell us exactly what is happening in that child's nervous system.
Why can the same touch feel different?
Touch begins with signals from the body, but what a person experiences also depends on how the nervous system processes them. The stimulus, its processing and the resulting sensation are related, not identical. A fabric that feels soft to one person can be intensely uncomfortable to another. Similar-looking skin does not establish an identical experience.
Sensory differences can involve greater sensitivity, reduced sensitivity, or a mixture that changes with context and health. One person may avoid some sensations and seek others. This is more accurate than claiming that every neurodivergent brain receives a fixed multiple of “unfiltered” information.1
Listen when a child reports pain. Check the garment, seams, fit, temperature and situation; offer a tolerable alternative. Skin irritation, injury and other physical causes still need consideration. Do not automatically attribute new or persistent pain to autism or dismiss it because another person can tolerate the sensation. Seek appropriate clinical assessment.
Why might a bodily signal not lead to action?
Interoception concerns signals about the body's internal state, such as hunger, thirst or needing the toilet. Recognising a signal, interpreting it, communicating it and acting on it are separate parts of the situation.1 A child may notice a need but be absorbed in an activity, unsure how to ask, unable to leave, or worried about the available toilet.
Ask what the child notices and what gets in the way. Make water, breaks and a suitable toilet accessible; use agreed reminders when helpful. Do not assume an accident proves indifference or that every difficulty reflects reduced body awareness. New bodily symptoms need medical attention appropriate to the symptom.
Why does ability not guarantee consistent performance?
| Part of the task | What to investigate |
|---|---|
| Attention and regulation | Can the child find the relevant information, stay with it and shift when needed? Are instructions competing with noise, discomfort or other demands? |
| Planning and movement | Is the sequence clear? Can the child organise and coordinate the movement required? Knowing the goal does not establish that these steps are easy. |
| Effort and reward | Does the child understand the future benefit? Separately, can they start and sustain effort through delay, discomfort or repeated mistakes? |
| Conditions today | What changed in sleep, pain, health, predictability, assistance or workload? Ask about the child's experience before assuming lost motivation. |
These questions organise observation; they do not identify a neural cause or diagnose a condition. Brain networks and chemical signalling contribute to attention and action, but a difficult afternoon cannot reveal a particular neurotransmitter level. Abilities and daily functioning need separate attention.
Adapt the task and environment while investigating persistent difficulties. A visible first step, accessible instruction, timely feedback and support for a difficult movement may help different parts of the problem. A reward cannot make an inaccessible task accessible on its own, and a child need not earn relief from pain or overload.
Why might a stimulant improve regulation?
“Stimulant” does not mean that every observable action becomes more energetic. These medicines can improve attention and regulation, making someone appear more settled. This is not the same as sedation. Their effects on focus are not exclusive to ADHD, so improvement after medication is not a diagnostic test.2
Methylphenidate affects dopamine and noradrenaline signalling, including blocking their reuptake. Its official label also states that its therapeutic mode of action in ADHD is not known.3 Knowing a drug's pharmacology does not prove that an individual has a simple shortage of one chemical. It does not tell us which treatment is appropriate for that child.
“Isn’t cocaine a stimulant too?”
Yes. Cocaine and several ADHD medicines belong to the broad class of central nervous system stimulants. That shared class does not make them the same substance or the same exposure. Molecule, formulation, route, speed of delivery, dose and pattern of use matter. Oral prescribed treatment under monitoring is different from uncontrolled exposure; extended-release formulations are designed to change delivery over time.43
The distinction does not erase risk. Prescription stimulants can be misused and can cause dependence and serious harm. The prescriber must assess suitability and risks, explain safe use and monitor benefit and adverse effects. Do not share medication, change its delivery or use someone else's response to decide a diagnosis.
Non-stimulant medicines are also options in ADHD care; choice depends on clinical assessment, response, tolerability and applicable guidance.5 Medication does not remove learning, communication, sensory or environmental needs. It does not replace accessible teaching or a safe relationship.
The useful question is whether treatment helps the person's daily life with acceptable adverse effects. Include the child's account, sleep, appetite, growth and relevant physical monitoring in review with the clinician. Do not treat unusual quietness as proof of success. Medication needs continuing review; this page gives no dosing or individual treatment recommendation.
Why might yesterday’s support fail today?
The child and the surrounding demands both change. A noisy room, illness, poor sleep, a different adult, a longer day or a new social expectation may alter what is manageable. A previously useful adjustment can become insufficient. That calls for checking the explanation and conditions, not automatically blaming the child or family.
Group research helps identify questions and possible mechanisms. It does not explain every individual's pain, action or response. A mechanism found in a particular genetic subgroup or an animal experiment cannot simply be applied to all autistic children. Useful support can begin before every biological question has been answered.
What to notice
- What sensation or difficulty does the child describe, and in which conditions?
- What help was present; what changed; how much effort or recovery was needed?
- Which question remains unresolved, and who will review it?
If the explanation or support is not helping, ask for a review.
Sources and limits
- National Autistic Society — Autism and sensory processing ↩
- NIMH — Mental health medications: stimulants ↩
- DailyMed — Concerta official US label, §§5, 9, 12.1–12.3 ↩
- SAMHSA (2021) — Treatment for stimulant use disorders, Chapter 2 ↩
- NICE NG87 — ADHD: diagnosis and management; recommendations 1.3–1.5 ↩
Sensory guidance describes patterns, not a laboratory explanation for a particular child's pain. The medication sources are an official overview, a US product label, UK guidance and a US clinical reference; they do not establish Greek availability, eligibility or individual prescribing. The task questions are explanatory illustrations, not a diagnostic instrument.